HIMS · CIK 0001773751 · operating
Hims & Hers Health operates a direct-to-consumer telehealth platform that connects patients with licensed healthcare providers across multiple jurisdictions. The company delivers prescription medications, over-the-counter products, and clinical services primarily through its website and mobile application, eliminating the need for in-person office visits for many conditions. Its product offerings span general wellness, skincare, sexual health, hair care, dermatology, weight loss, hormone health, and mental health treatments. The platform also provides laboratory testing services and post-consultation support to customers.
The company's revenue streams include prescription medication sales, non-prescription health and wellness products, cosmetic and supplement offerings, laboratory testing services, and medical consultations. Hims & Hers has expanded distribution beyond direct channels to include retail partnerships and in-store availability. The business operates across eight countries: the United States, United Kingdom, Canada, Germany, Republic of Ireland, France, Spain, and internationally in select markets.
As of the most recent data, Hims & Hers maintains approximately 2,442 full-time employees and is headquartered in San Francisco, California. The company is incorporated in Delaware and trades on the New York Stock Exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $0.51 | $0.57 | -3.8% | |
| 2024 | $0.53 | $0.58 | +581.8% | |
| 2023 | $-0.11 | $-0.11 | +65.6% | |
| 2022 | $-0.32 | $-0.32 | +44.8% | |
| 2021 | $-0.58 | $-0.58 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |